Drusolv Therapeutics is a clinical-stage drug company focused on development of a novel, high-dose statin for early intervention in a blinding eye disease called age-related macular degeneration (AMD).
Company Details
- Founded
- 2017
- Address
- 1425 Locust St Unit 7c, Philadelphia,pennsylvania 19102,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.drusolv.com
- Keywords
- Intrance Medical Systems.
- HQ
- Philadelphia, Pennsylvania
Drusolv Therapeutics Questions
Drusolv Therapeutics's website is http://www.drusolv.com
Drusolv Therapeutics's LinkedIn profile is https://www.linkedin.com/company/drusolv-therapeutics
Drusolv Therapeutics's industry is
Biotechnology Research
Drusolv Therapeutics's top competitors are
Fonseca Biosciences,
Ambrose Healthcare,
Qrono Inc.,
Epivario, Inc.,
Ggs Associates,
11.2 Capital,
Intrance Medical Systems,
Apeliotus Technologies,
Adaptdx Pro,
Baudax Bio.
Drusolv Therapeutics's categories are Biotechnology Research
Drusolv Therapeutics's founding year is 2017
